Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Kirsten Baillie1, Helen E Davies2, Samuel B K Keat1
1Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK.
Insights
Long COVID patients show elevated complement activation markers, suggesting a role for the complement system in the condition. These biomarkers could aid in diagnosing and treating long COVID with existing complement inhibitors.
Area of Science:
- Immunology
- Infectious Diseases
- Systems Biology
Background:
- Long COVID presents diverse ongoing symptoms post-SARS-CoV-2 infection, with unclear biological underpinnings.
- Complement system dysregulation is known in acute COVID-19 but unexamined in long COVID.
- Understanding long COVID mechanisms is crucial for diagnosis and treatment.
Purpose of the Study:
- Investigate the role of complement system activation and regulation in long COVID.
- Identify potential biomarkers for long COVID diagnosis.
- Explore therapeutic targets for long COVID.
Main Methods:
- Quantified complement proteins and activation/regulation markers in plasma from long COVID patients and healthy convalescents.
- Utilized age, ethnicity, sex, infection, and vaccine matching for sample groups.
- Employed generalized linear modeling for biomarker analysis.
Main Results:
- Significantly elevated classical, alternative, and terminal complement pathway activation markers in long COVID patients.
- A combination of four markers (iC3b, TCC, Ba, C5a) demonstrated a predictive power of 0.785 for long COVID.
- Other complement proteins and regulators also showed quantitative differences between groups.
Conclusions:
- Complement biomarkers show potential for facilitating long COVID diagnosis.
- Complement activation inhibitors may offer a therapeutic strategy for long COVID.
- This study highlights the complement system's involvement in long COVID pathogenesis.
Background:
Long COVID encompasses a heterogeneous set of ongoing symptoms that affect many individuals after recovery from infection with SARS-CoV-2. The underlying biological mechanisms nonetheless remain obscure, precluding accurate diagnosis and effective intervention. Complement dysregulation is a hallmark of acute COVID-19 but has not been investigated as a potential determinant of long COVID.
Methods:
We quantified a series of complement proteins, including markers of activation and regulation, in plasma samples from healthy convalescent individuals with a confirmed history of infection with SARS-CoV-2 and age/ethnicity/sex/infection/vaccine-matched patients with long COVID.
Findings:
Markers of classical (C1s-C1INH complex), alternative (Ba, iC3b), and terminal pathway (C5a, TCC) activation were significantly elevated in patients with long COVID. These markers in combination had a receiver operating characteristic predictive power of 0.794. Other complement proteins and regulators were also quantitatively different between healthy convalescent individuals and patients with long COVID. Generalized linear modeling further revealed that a clinically tractable combination of just four of these markers, namely the activation fragments iC3b, TCC, Ba, and C5a, had a predictive power of 0.785.
Conclusions:
These findings suggest that complement biomarkers could facilitate the diagnosis of long COVID and further suggest that currently available inhibitors of complement activation could be used to treat long COVID.
Funding:
This work was funded by the National Institute for Health Research (COV-LT2-0041), the PolyBio Research Foundation, and the UK Dementia Research Institute.
More Related Videos
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Humoral Immune Responses
Depression: Overview
